| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |